Drug Profile
Ephphatha 1000
Alternative Names: Ephphatha-1000Latest Information Update: 28 Aug 2020
Price :
$50
*
At a glance
- Originator Ensol Biosciences
- Class Cardiovascular therapies
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Aortic valve stenosis
Most Recent Events
- 28 Aug 2020 No recent reports of development identified for research development in Aortic-valve-stenosis in South Korea
- 26 Jul 2016 Early research in Aortic valve stenosis in South Korea (unspecified route)